Menu
This security has been delisted
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Gt Biopharma Inc.

WKN: A402U5 / Name: Gt Biopharma Inc. / Stock / ? /

€4.77
-

Crescent Biopharma Inc.

WKN: A41BDZ / Name: Crescent Biopharma Inc. / Stock / ? /

?
-4.840%

Sutro Biopharma Inc.

WKN: A41VMF / Name: Sutro Biopharma Inc. / Stock / ? /

€19.90
-3.920%

Matinas BioPharma Holdings Inc

WKN: A2DMQP / Name: Matinas BioPharma Holdings Inc / Stock / Biotechnology & Medical Research / Small Cap /

€0.084
0.550%

Immuneonco Biopharma.(sh) Inc.

WKN: A3ETCF / Name: Immuneonco Biopharma.(sh) Inc. / Stock / ? /

€0.50
-2.910%

Matinas Biopharma Holdings Inc

WKN: A403NH / Name: Matinas Biopharma Holdings Inc / Stock / ? /

€2.69
-

Aytu Biopharma Inc.

WKN: A3D38R / Symbol: AYTU / Name: Aytu Biopharma / Stock / Micro Cap /

€1.76
-1.120%

Benitec Biopharma Inc.

WKN: A2P06Q / Name: Benitec Biopharma / Stock / Biotechnology & Medical Research / Micro Cap /

€0.19
-3.590%

PDL BioPharma Inc.

WKN: A0H1J1 / Symbol: PDLI / Name: PDL BioPharma / Stock / Biotechnology & Medical Research / Small Cap /

€2.22
-

Cue Biopharma Inc

WKN: A2JAT5 / Symbol: CUE / Name: Cue Biopharma / Stock / Small Cap /

€0.24
-10.440%

Sutro Biopharma Inc

WKN: A2N6SG / Symbol: STRO / Name: Sutro Biopharma / Stock / Biotechnology & Medical Research / Small Cap /

€0.62
-8.510%

Xeris Biopharma Holdings Inc.

WKN: A3C4ZC / Symbol: XERS / Name: Xeris Biopharma / Stock / Biotechnology & Medical Research / Small Cap /

€4.86
3.150%

Eiger Biopharmaceuticals Inc

WKN: A2AF9X / Symbol: CLDN / Name: Eiger Biopharma / Stock / Biotechnology & Medical Research / Small Cap /

€0.20
0.950%

Alder Biopharmaceuticals Inc

WKN: A113TL / Symbol: ALDR / Name: Alder / Stock / Biotechnology & Medical Research / Small Cap /

€16.60
-

GT Biopharma (GTBP) Upgraded to Buy: Here's What You Should Know
GT Biopharma (GTBP) Upgraded to Buy: Here's What You Should Know

GT Biopharma, Inc. (GTBP) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one

GT Biopharma (GTBP) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
GT Biopharma (GTBP) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Shares of GT Biopharma, Inc. (GTBP) have been struggling lately and have lost 6.6% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could mean

Hemispherx Biopharma

WKN: A2PLTT / Symbol: HEB / Name: Hemispherx Bio / Stock / Biotechnology & Medical Research / Micro Cap /

-
-

Albireo Pharma Inc.

WKN: A2DF99 / Symbol: ALBO / Name: Albireo Pharma / Stock / Biotechnology & Medical Research / Small Cap /

€41.82
0.290%

Ocuphire Pharma Inc.

WKN: A2QG4Z / Symbol: OCUP / Name: Ocuphire Pharma / Stock / Biotechnology & Medical Research / Small Cap /

€4.09
-1.920%

Cti Biopharma Corp

WKN: A2DJWX / Symbol: CTIC / Name: CTi Biopharma / Stock / Biotechnology & Medical Research / Micro Cap /

€8.35
-